<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Hypocalcemia":1,
"Hypoparathyroidism":2,
"Pediatric population":1,
"Total thyroidectomy":2,
"Extrathyroidal extension":4,
"thyroid cancer":21,
"thyroidectomy":9,
"APC":1,
"Cribriform-morular":1,
"Cribriform-morular variant papillary thyroid carcinoma":1,
"FAP":1,
"Familial adenomatous polyposis":1,
"Thyroid carcinoma":5,
"Wnt":1,
"β-catenin":1,
"Childhood cancer survivors":1,
"Cyclophosphamide":1,
"Endocrine late effects":1,
"Hematopoietic stem cell transplantation":1,
"Radiation therapy":1,
"BAVANS":1,
"Lymph node dissection":3,
"Video-assisted neck surgery":1,
"diagnosis":4,
"gastric cancer":3,
"lncRNA PTCSC3":1,
"prognosis":12,
"BRAF gene":1,
"Lymph node metastasis (LNM)":1,
"PAQR3":1,
"Papillary thyroid microcarcinoma":2,
"preconception planning":1,
"pregnancy":3,
"thyroid nodules":2,
"3,5,3′-Triiodo-L-thyronine (T3)":1,
"Degranulation":1,
"Integrin":1,
"L-Thyroxine (T4)":2,
"Metastasis":1,
"Thyroid hormone receptors":1,
"Tumor cell invasiveness":1,
"Korea":1,
"mass screening":1,
"mortality":3,
"thyroid neoplasms":6,
"ultrasonography":6,
"contralateral thyroid lobe":1,
"lobectomy":1,
"nodules":1,
"papillary thyroid carcinoma":25,
"ultrasound":5,
"TIRADS":1,
"risk stratification":1,
"small thyroid nodules":1,
"thyroid carcinomas":1,
"Biomarkers":1,
"Papillary thyroid cancer":6,
"Patient stratification":1,
"Tumor progression":1,
"ear, nose and throat/otolaryngology":1,
"head and neck surgery":1,
"otolaryngology/ENT":1,
"thyroid disease":1,
"INI1":1,
"Metastatic cancer":1,
"Rhabdoid":1,
"SMARCB1":1,
"Colorectal cancer":2,
"ablation":1,
"liver metastasis":1,
"resection":1,
"simultaneous treatment":1,
"PEI":1,
"nodule":1,
"nodulus":1,
"sclerotherapia":1,
"sclerotherapy":1,
"thyreoidea":1,
"thyroid":8,
"FAT1":1,
"FAT4":1,
"copy number alteration":1,
"molecular subtype":1,
"multi-omics profiling":1,
"sporadic medullary thyroid carcinoma":2,
"CAT":1,
"GPX":1,
"MnSOD":1,
"polymorphism":1,
"Clinical research":1,
"Fibroblast growth factor receptor":1,
"Lenvatinib":3,
"Molecular biology":2,
"anastomosis":1,
"cabozantinib":1,
"medullary thyroid carcinoma":8,
"tyrosine kinase inhibitors":1,
"FOXC1":1,
"Hepatocellular carcinoma":1,
"TRIP6":1,
"lymph nodes metastases":1,
"recurrence":5,
"response to therapy":1,
"Bioelectrical impedance analysis":1,
"Weight loss":1,
"antiresorptive treatment":1,
"bone metastasis":1,
"medullary thyroid cancer":2,
"skeletal-related adverse events":1,
"American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS)":1,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"fine-needle aspiration (FNA)":1,
"risk of malignancy":1,
"thyroid cytology":1,
"Fine-needle aspiration":3,
"Neoplasm":1,
"Thyroid Imaging Reporting And Data System":1,
"delphian lymph node":1,
"lymph node metastasis":8,
"tumor":2,
"Free flap":1,
"Immediate reconstruction":1,
"Locoregional recurrence":2,
"Postmastectomy radiation therapy":1,
"rat hepatocyte":1,
"sirtuin":1,
"thyroid hormone":3,
"thyronamine":1,
"BRAF":3,
"Follicular variant of papillary thyroid carcinoma":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"RAS":3,
"Cell cycle":1,
"Cell proliferation":1,
"HTR3A":1,
"miR-1256":1,
"calcitonin":4,
"carcinoembryonic antigen":1,
"neuron-specific enolase":1,
"Lateral neck lymph node metastasis":1,
"advanced thyroid cancer":1,
"distant metastasis":3,
"genetic profile":1,
"next generation sequencing":1,
"Antithyroid drugs":1,
"Chronic hepatitis C":1,
"Hyperthyroidism":1,
"Hypothyroidism":4,
"Thyroid autoimmunity":1,
"Distant metastases":1,
"FT-UMP":1,
"MI-FTC":1,
"Radioiodine therapy":2,
"WDT-UMP":1,
"RET":1,
"association study":1,
"haplotype":1,
"polymorphisms":1,
"Next-generation DNA sequencing":1,
"RET protooncogene":1,
"HOST2":1,
"Let-7b":1,
"STAT3":1,
"TNBC":1,
"ceRNA":1,
"AUS":1,
"FLUS":1,
"FNA":1,
"nuclear atypia":1,
"Anaplastic thyroid carcinoma":4,
"Clinical practice guidelines":1,
"Follicular thyroid carcinoma":4,
"Electrochemiluminescence immunoassay (ECLIA)":1,
"Radioimmunoassay (RIA)":1,
"BAG5":1,
"Fibronectin 1":1,
"anatomic landmarks":1,
"clinical applied anatomy":1,
"endoscopic thyroidectomy":2,
"technical":1,
"Artificial neural network":1,
"Follicular neoplasm":1,
"Machine learning":1,
"Support vector machine":2,
"Cardiovascular disease":1,
"Hyperlipidemia":1,
"Hypertension":1,
"Medicare":1,
"Nonalcoholic fatty liver disease":1,
"Outcomes":1,
"Resource utilization":1,
"Trends":2,
"Type 2 diabetes":1,
"GA binding protein transcription factor alpha":1,
"hypoxia-inducible factor 1α":1,
"lysine-specific demethylase 1":1,
"microRNA-146a":1,
"transcription factor":1,
"Autophagy":2,
"mTOR":1,
"Microscopic margin":1,
"Radioactive iodine treatment":1,
"Treatment response":1,
"ETS variant 5":1,
"Epithelial-mesenchymal transition":2,
"Estrogen receptor":1,
"PIK3CA":2,
"endoscopic parathyroidectomy":1,
"minimally invasive surgery":1,
"remote access surgery":1,
"transoral endocrine surgery":1,
"transoral parathyroid surgery":1,
"transoral thyroid surgery":1,
"Adult":1,
"Case report":8,
"Magnetic resonance imaging":2,
"Pathology":1,
"Pituitary blastoma":1,
"Alzheimer disease":1,
"Anterior callosal angle":1,
"Callosal angle":1,
"Idiopathic normal pressure hydrocephalus":1,
"Advanced thyroid carcinoma":1,
"Proteinuria":1,
"UPCR":1,
"malignancy risk":1,
"thyroid malignancy":1,
"thyroid nodule":4,
"thyroid nodule size":1,
"BHLHE40":1,
"Cellular senescence":1,
"DEC1":1,
"Prostate cancer":1,
"Nomogram":3,
"Renal cell carcinoma":1,
"SEER":1,
"Sarcomatoid":1,
"Computed tomography":1,
"lymphoma":1,
"synchronous malignancy":1,
"Clear cell renal cell carcinoma":1,
"Epigenetics":1,
"Prognostic signature":1,
"Survival analysis":1,
"m6A methylation":1,
"Ovarian Sertoli-Leydig cell tumors":1,
"Slcts":1,
"Deiodination":1,
"FT3/FT4":1,
"Refractory disease":1,
"Regorafenib":1,
"Survival":1,
"COVID-19":2,
"head and neck advocacy":1,
"head and neck cancer support":1,
"not-for-profit":1,
"AR pathway":1,
"Hormone":1,
"PI3k/Akt pathway":1,
"Sertoli cell":1,
"Spermatogenesis":1,
"cAMP/PKA pathway":1,
"Papillary carcinoma of the thyroid":1,
"Bioinformatics":2,
"N(6)-methyladenosine":1,
"The Cancer Genome Atlas":1,
"Colitis":1,
"Diabetes":1,
"Hypophysitis":1,
"Immune checkpoint inhibitors":1,
"Pneumonitis":1,
"Thyroid disorders":1,
"Carcinoma papilar de tiroides":1,
"Cirugía radioguiada":1,
"Radioguided surgery":1,
"Recurrencia cervical":1,
"Recurrent cervical cancer":1,
"low risk":1,
"therapy":1,
"Adolescent":2,
"Cancer":3,
"Childhood":1,
"Incidence":2,
"Netherlands":1,
"Stage at diagnosis":1,
"Leukocytosis":1,
"Paraneoplastic syndrome":1,
"BRAFV600E mutation":1,
"NIFTP":1,
"follicular variant of papillary thyroid cancer":1,
"radioactive iodine therapy":2,
"indeterminate cytology":1,
"molecular diagnostics":1,
"personalized healthcare":1,
"variant detection":1,
"head and neck cancer":2,
"head and neck squamous cell carcinoma":2,
"salivary gland cancer":1,
"skin cancer":1,
"IGF-1":2,
"IGF-1R":1,
"angiogenesis":2,
"breast cancer":3,
"lncRNA NR2F1-AS1":1,
"Sutton naevus":1,
"melanoma-associated hypopigmentation":1,
"neuroendocrine tumour":1,
"vitiligo":1,
"halo naevus":1,
"hőablatio":1,
"pajzsmirigygöb":1,
"radiofrequency ablation":2,
"rádiófrekvenciás ablatio":1,
"thermal ablation":1,
"ultrahang":1,
"HOTAIR":1,
"lncRNA":1,
"131I radioiodine":1,
"differentiated thyroid cancer":2,
"maximum permissible dose":1,
"radiation effective dose":1,
"Abemaciclib":1,
"CDK4/6 inhibitor":1,
"DOCK180":1,
"JAK/STAT/AMPK":1,
"invasion":1,
"migration":2,
"proliferation":2,
"Hepatic hilar plate":1,
"Hepatic resections":1,
"Liver anatomy":1,
"Liver neoplasms":1,
"Hashimoto's thyroiditis":2,
"familial hypocalciuric hypercalcaemia":1,
"follicular variant papillary thyroid carcinoma":1,
"primary hyperparathyroidism":2,
"papillary":3,
"tumor stem cells":1,
"Cardiac rupture":1,
"Cardiopulmonary resuscitation":1,
"Neoadjuvant chemotherapy":1,
"Physiotherapy":1,
"Thymoma":1,
"Alberta":1,
"Canada":1,
"Demographics":1,
"Epidemiology":1,
"Survivors":1,
"Survivorship":1,
"apoptosis":1,
"integrin αvβ3":1,
"tetraiodothyroacetic acid (tetrac)":1,
"radiomics":1,
"M918T mutation":2,
"RET proto-oncogene":2,
"Thyroid neoplasm":1,
"mixed medullary-follicular carcinoma":1,
"multiple endocrine neoplasia type 2B":1,
"PHTS":1,
"PTEN":1,
"Virchow–Robin spaces":1,
"cMRI":1,
"children":1,
"enlarged perivascular spaces":1,
"macrocephaly":1,
"white matter abnormalities":1,
"BRAF mutation":1,
"HMGB1":1,
"Vemurafenib":1,
"Child":1,
"Surgical procedures, operative":1,
"Hürthle cell carcinoma":2,
"SETD2 loss-of-function mutations":1,
"poorly differentiated thyroid cancer":1,
"Follicular thyroid cancer":1,
"Oncocytic/oxyphilic follicular carcinoma":1,
"Radioablation":1,
"Anaplastic carcinoma":2,
"Immunohistochemistry":2,
"Well-differentiated carcinoma":1,
"Adenoma":1,
"Gallbladder":1,
"Preinvasive neoplasm":1,
"Pyloric":1,
"Tubular&nbsp":1,
"Renal cell carcinoma (RCC)":1,
"targeted drugs":1,
"thyroid function":1,
"Small-cell lung cancer (SCLC)":1,
"durvalumab":2,
"immunotherapy":1,
"third-line treatment":1,
"Dedifferentiated chondrosarcoma":1,
"Differential diagnosis":1,
"Bone metastases":1,
"Bone mineral density":1,
"Differentiated thyroid carcinoma":2,
"Fractures":1,
"Levothyroxine":1,
"TSH suppression":1,
"BRAFV600E":1,
"TERT promoter":1,
"TP53":1,
"Doubling rate":1,
"Kinetic analysis of the growth rate":1,
"Tumor volume":1,
"Biomarker":1,
"Chemotherapy sensitivity":1,
"Lung neoplasms":1,
"TTF-1":1,
"Lung":1,
"Meta-analysis":1,
"Metastatic":1,
"PAX8":1,
"Primary":1,
"dexamethasone":1,
"microgravity":1,
"space environment":1,
"low-risk thyroid cancer":1,
"shared decision making":1,
"thyroid lobectomy":1,
"PDGF":1,
"Vit D":1,
"age period cohort":1,
"epithelial cancer":1,
"sex ratios":1,
"Laryngeal carcinoma":1,
"Malignancy larynx":1,
"Thyroid invasion":1,
"Lymphatic metastasis":2,
"Papillary thyroid carcinoma (PTC)":1,
"Tumour location":1,
"erlotinib":1,
"non-small cell lung cancer":2,
"p63":1,
"prediction":1,
"prognostic":1,
"thyroid transcription factor one":1,
"biological characteristics":1,
"contrast-enhanced ultrasound":1,
"risk factors for prognosis":1,
"PDK-1":1,
"p-Akt":1,
"sPD-L1":1,
"childhood and adolescence":1,
"iodine-131":1,
"long-term complications":1,
"second primary malignancy":1,
"young females":1,
"EZH2":1,
"LOXL4":1,
"Macrophage":2,
"miR-29b/miR-30d":1,
"thyroglobulin antibodies":1,
"miR-34a":1,
"clinical application":1,
"linc-ROR":1,
"long noncoding RNA":1,
"mechanisms":1,
"CT":1,
"MRI":1,
"ectopic thyroid":1,
"multimodality":1,
"thyroid scintigraphy":1,
"secondary tumor":1,
"thyroid gland":1,
"tumor biology":1,
"brachioradialis":1,
"flexor digitorum superficialis":1,
"posterior pharyngeal wall":1,
"radial forearm free flap":1,
"soft tissue necrosis":1,
"Ex, extrathyroidal extension":1,
"PTC, papillary thyroid carcinoma":1,
"Positive extrathyroidal extension":1,
"Prophylactic lateral neck dissection":1,
"RAI, radioactive iodine":2,
"RFS, recurrence free survival":1,
"pLND, Prophylactic lateral neck dissection":1,
"cancer stem cells":1,
"epiblast":1,
"human embryonic stem cells":1,
"human induced pluripotent stem cells":1,
"oncogenesis":1,
"organoids":1,
"reprogram enablement":1,
"reprogramming":1,
"MEN 1 gene":1,
"RET gene":1,
"multiple endocrine neoplasia type 1":1,
"multiple endocrine neoplasia type 2":1,
"PTC":1,
"dermatologic surgery":1,
"ethanol injection":1,
"long-term prognosis":1,
"skin metastasis":1,
"neuropsychiatric":1,
"psychosis":1,
"BGC-823 cells":1,
"Gastric neoplasms":1,
"MiR-141-3p":1,
"NF-κB signaling pathway":1,
"long non-coding RNA":1,
"messenger RNA":1,
"microRNA":1,
"brain metastasis":1,
"surgical resection":1,
"FANCA gene":1,
"literature review":1,
"multiple primary malignancy":1,
"CT, computed tomography":1,
"Cavernous hemangioma":1,
"FLAIR, fluid attenuation inversion recovery":1,
"GRE, gradient echo sequences":1,
"Intracranial hemorrhagic metastasis":1,
"MRI, magnetic resonance imaging":1,
"SWI, susceptibility-weighted imaging":1,
"RCAS1":1,
"thyroidbiomarkers":1,
"thyroidcancer":1,
"thyroidneoplasm":1,
"Endocrine":1,
"I-131 therapy":1,
"Oncology: Endocrine":1,
"Radionuclide Therapy":1,
"tumor thrombus":1,
"acute myeloid leukemia":1,
"immunomodulatory drugs":1,
"lenalidomide":1,
"pomalidomide":1,
"thalidomide":1,
"Familial papillary thyroid cancer":1,
"Outcome":1,
"Recurrences":1,
"Sporadic papillary thyroid cancer":1,
"Conversion surgery":1,
"Peritoneal dissemination":1,
"Breast neoplasms":2,
"Circulating tumor DNA":1,
"Neoadjuvant therapy":1,
": Multiple endocrine neoplasia type 2B":1,
"Chinese":1,
"extra-endocrine signs":1,
"Cancer survivors":1,
"Conformal":1,
"Radiotherapy":1,
"Radiotherapy dosage":1,
"NTRK gene rearrangement":1,
"cytomorphology":1,
"Fibronectin-1":1,
"Ursolic acid":1,
"Case-report":1,
"Congenital digestive system abnormalities":1,
"Hirschsprung disease":1,
"Neurocristopathy":1,
"REarranged during Transfection":1,
"Pectoralis muscle":1,
"trachea":1,
"risk factors":1,
"AHNAK2":1,
"diagnostic biomarker":1,
"immune infiltration":1,
"prognostic biomarker":1,
"anal carcinoma":1,
"biliary adenocarcinoma":1,
"cervical carcinoma":1,
"endometrial carcinoma":1,
"mesothelioma":1,
"neuroendocrine tumors":1,
"salivary gland carcinoma":1,
"small-cell lung carcinoma":1,
"vulvar carcinoma":1,
"Central lymph node metastasis":1,
"Cell movement":1,
"Dipeptidyl peptidase-IV inhibitors":1,
"NF-E2 transcription factor":1,
"Neoplasm invasiveness":1,
"Axillary approach":1,
"Surgical procedures, minimally invasive":1,
"TGF-β1":1,
"aerosolized":1,
"radiation induced lung fibrosis":1,
"Level Ⅵ":1,
"Paratracheal neck dissection":1,
"Upper limit of paratracheal neck dissection":1,
"SEER program":1,
"age":2,
"lymph node ratio":1,
"immunoassay":1,
"procalcitonin":1,
"reflex test":1,
"Thyroid hemiagenesis":1,
"Body mass index":1,
"capsular invasion":1,
"thyroid isthmus nodule":1,
"MEN2A":1,
"MEN2B":1,
"ganglioneuromatosis":1,
"gastrointestinal symptoms":1,
"multiple endocrine neoplasia":2,
"quality of life":1,
"paediatric patient":1,
"short stature":1,
"MEN 2b":1,
"Autoimmune polyendocrinopathy":1,
"auto-immune diabetes":1,
"thyroiditis":1,
"Classification":1,
"Clinical decision-making":1,
"Mutation":1,
"Parathyroid adenoma":1,
"Thyroid adenoma":1,
"M2-like TAMs":1,
"Wnt1":1,
"Wnt3a":1,
"tumor dedifferentiation":1,
"Metastases to adrenal glands":1,
"Thyroid cancer metastasis":1,
"vascular endothelial growth inhibitor":1,
"adaptive radiotherapy":1,
"dosimetric comparative study":1,
"intensity-modulated radiotherapy":1,
"nasopharyngeal carcinoma":1,
"proton beam therapy":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
